ScoreWhy is Jaguar Health, Inc. ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%
- Poor long term growth as Operating profit has grown by an annual rate -4.43% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.01 times
2
With a growth in Net Sales of 526.65%, the company declared Outstanding results in Mar 26
- OPERATING CASH FLOW(Y) Highest at USD -7.54 MM
- ROCE(HY) Highest at 0%
- DEBTORS TURNOVER RATIO(HY) Highest at 35.43 times
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -97.49%, its profits have fallen by -4.6%
4
FIIs have increased holdings this quarter and now hold 3.38% of the company
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -97.49% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Jaguar Health, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jaguar Health, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Jaguar Health, Inc.
-97.33%
-0.01
3041.07%
S&P 500
20.78%
1.56
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.22%
EBIT Growth (5y)
-4.43%
EBIT to Interest (avg)
-10.45
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
7.42
Sales to Capital Employed (avg)
0.26
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.92%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.23
EV to EBIT
-0.88
EV to EBITDA
-0.94
EV to Capital Employed
0.87
EV to Sales
2.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-99.22%
ROE (Latest)
-567.44%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend40What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -7.54 MM
ROCE(HY)
Highest at 0%
DEBTORS TURNOVER RATIO(HY)
Highest at 35.43 times
NET SALES(Q)
Highest at USD 20.27 MM
RAW MATERIAL COST(Y)
Fallen by -68.19% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -171.02 %
INVENTORY TURNOVER RATIO(HY)
Highest at 0.71 times
OPERATING PROFIT(Q)
Highest at USD 10.7 MM
OPERATING PROFIT MARGIN(Q)
Highest at 52.79 %
PRE-TAX PROFIT(Q)
Highest at USD 9.69 MM
NET PROFIT(Q)
Highest at USD 9.81 MM
EPS(Q)
Highest at USD -13.6
-4What is not working for the Company
INTEREST(9M)
At USD 0.7 MM has Grown at inf%
Here's what is working for Jaguar Health, Inc.
Net Sales
At USD 20.27 MM has Grown at 604.44%
over average net sales of the previous four periods of USD 2.88 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 9.69 MM has Grown at 185.86%
over average net sales of the previous four periods of USD -11.28 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 9.81 MM has Grown at 188.08%
over average net sales of the previous four periods of USD -11.14 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -7.54 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 20.27 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Debtors Turnover Ratio
Highest at 35.43 times and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Operating Profit
Highest at USD 10.7 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 52.79 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 9.69 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 9.81 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -13.6
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at -171.02 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 0.71 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -68.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jaguar Health, Inc.
Interest
At USD 0.7 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
